RS 980
Latest Information Update: 21 Jul 1998
At a glance
- Originator Nonindustrial source
- Class Antiretrovirals
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV-1 infections
Most Recent Events
- 21 Jul 1998 No-Development-Reported for HIV-1 infections in Italy (Unknown route)
- 12 Jun 1995 New profile
- 12 Jun 1995 Preclinical development for HIV-1 infections in Italy (Unknown route)